Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
368 studies found for:    "Benzoates"
Show Display Options
Rank Status Study
1 Recruiting Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
Condition: UCDs (The Data May be Helpful in the Treatment of UCDs.)
Interventions: Drug: Sodium Benzoate;   Drug: Sodium Phenylbutyrate;   Drug: Phenylbutyrate and Benzoate
2 Recruiting Adaptive Phase II Study to Evaluate the Safety & Efficacy of Sodium Benzoate as an Add-on Treatment for Schizophrenia in Adolescents
Condition: Schizophrenia
Interventions: Drug: NaBen® (Sodium Benzoate);   Drug: Placebo
3 Withdrawn Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
Condition: Attenuated or Transient Psychosis
Interventions: Drug: Sodium Benzoate;   Drug: Placebo
4 Completed Effects of a Food Preservative on Glucose Homeostasis
Condition: Overweight
Interventions: Other: benzoate containing test drinks;   Other: non sodium benzoate containing test drinks
5 Withdrawn Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
6 Completed Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
Condition: Bacterial Infections
Interventions: Drug: Metronidazole benzoate;   Drug: Flagyl 125 mg/5 ml oral suspension;   Drug: Flagyl 400 mg Tablets
7 Unknown  Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
Conditions: Obstructive Sleep Apnea;   Enlargement of Tonsil or Adenoid
Interventions: Drug: Caffeine and sodium Benzoate 10 mg/kg IV;   Drug: Caffeine and Sodium Benzoate 20 mg/kg IV;   Drug: 0.9 NS Saline
8 Completed Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis
Condition: Chronic Periodontitis
Interventions: Procedure: Full-mouth periodontal debridement;   Drug: Metronidazole tablet;   Drug: placebo gel;   Drug: Metronidazole benzoate gel
9 Completed Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors
Interventions: Drug: Sodium Benzoate;   Drug: Sodium Phenylacetate;   Drug: Sodium Phenylbutyrate;   Behavioral: Dietary Intervention
10 Not yet recruiting Study to Evaluate Safety & Efficacy of NaBen as Add-on Treatment for Negative Symptoms of Schizophrenia in Adults
Condition: Schizophrenia
Interventions: Drug: NaBen®;   Other: Placebo
11 Completed
Has Results
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
12 Completed
Has Results
Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Condition: Migraine Disorders
Interventions: Drug: rizatriptan benzoate (5 mg);   Drug: rizatriptan benzoate (10 mg);   Drug: Rizatriptan 5 mg Placebo;   Drug: Rizatriptan 10 mg Placebo
13 Completed
Has Results
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Condition: Acute Migraine With or Without Aura in Adolescents
Intervention: Drug: rizatriptan benzoate
14 Completed
Has Results
A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Condition: Migraine
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: placebo
15 Completed
Has Results
Treatment of Multiple Attacks of Acute Migraine (0462-025)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
16 Completed
Has Results
Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
Conditions: Cancer;   Pain
Interventions: Drug: Caffeine;   Drug: Normal saline
17 Completed
Has Results
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
18 Completed
Has Results
MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: placebo
19 Completed
Has Results
Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
Condition: Migraine
Interventions: Drug: Comparator: rizatriptan benzoate;   Drug: Comparator: Placebo
20 Completed Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years